As Asian countries continue to deal with growing elderly populations and the proliferation of heart disease and cancer as leading causes of death, healthcare systems are being revised and new medical device imports are in high demand. Despite Japan's strict regulatory regime... Read More
Despite sluggish economies in some countries, Asia still represents future growth opportunities in healthcare products. Over the next 20 years, Asian healthcare markets are expected to grow at a rate two and a half times that of the West. A rising standard... Read More
Physicians often run (and sometimes own) local hospitals in Japan. Because of this, they are the key decision-makers for most major hospital purchases. Thus, it is imperative that a manufacturer’s medical device appeals to Japanese doctors during both the pre-approval and marketing... Read More
The popularity of foreign-made pharmaceuticals in China continues to rise, with imports and joint-venture products accounting for one-third of the Chinese pharmaceutical markets. In some areas of China, especially Guangdong province (which neighbors Hong Kong), foreign-made pharmaceuticals can account for as much... Read More
Singapore, a tiny city-state with a population of only 4 million, has one of the world’s strongest economies, with GDP per capita of US$28,000, similar to that of the United States. Singapore spends approximately US$2.5 billion per year on healthcare, for an... Read More
China’s $22.5 billion pharmaceutical market is the second largest in Asia, after Japan, and foreign drug imports and pharmaceutical investment in China will likely increase as China enters the WTO. Anticipating an influx of foreign pharmaceuticals, the Chinese government established the State... Read More
The Thai market for healthcare products grew an estimated 12 percent last year. The next few years should see similar or even greater growth. With heart disease and cancer the two major causes of death in Thailand, and increasing numbers of Thais... Read More
The Vietnamese government has announced it will invest up to $1.5 billion in the pharmaceutical manufacturing sector over the next 10 years. The money will be used for a variety of programs, including upgrading technology to meet Good Manufacturing Practice standards, developing... Read More
Regulations in Japan are rapidly changing and the information in this news brief from 2001 may provide outdated information on Japan’s current medical industry. For updated and in-depth information on Japan’s in-country caretaker and distributor search process, please visit our Japan Distributor Search page. A... Read More
Once severely restrictive in practice and economically limited, markets in China are beginning to hold brighter prospects for successful entry by foreign manufacturers and suppliers. Medical product companies looking for product import, distribution and manufacturing opportunities in China will find promise in... Read More